Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: Lack of need for thyroxine supplementation

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 10, 1998, Pages 3493-3497

  Wyatt, David T ^a   Gesundheit, Neil ^b   Sherman, Barry ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LIOTHYRONINE; PROTIRELIN; SOMATREM; THYROID HORMONE; THYROTROPIN; THYROXINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; REFERENCE VALUES; THYROID HORMONES; THYROXINE;

EID: 0031741460     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.10.3493     Document Type: Article

References (40)

1. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP. 1971 Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child. 46:745-782.
2. Aceto T, Frasier SD, Hayles AB, et. al. 1972 Collaborative study of the effects of human growth hormone in growth hormone deficiency. I. First year of therapy. J Clin Endocrinol Metab. 35:483-496.
3. Cacciari E, Cicognani A, Pirazzoli P, et. al. 1979 Effect of long-term growth hormone administration on pituitary-thyroid function in idiopathic hypopituitarism. Acta Pediatr Scand. 68:405-409.
4. Winter RJ, Thompson RG, Green OC. 1979 Serum cholesterol and triglycerides in children with growth hormone deficiency. Metabolism. 28:1244-1249.
5. Municchi G, Malozowski S, Nisula BC, Cristiano A, Rose SR. 1992 Nocturnal thyrotropin surge in growth hormone deficient children. J Pediatr. 121:214-220.
6. Rose SR, Leong GM, Yanovski JA, et. al. 1995 Thyroid function in non-growth hormone deficient short children during a placebo-controlled double blind trial of recombinant growth hormone therapy. J Clin Endocrinol Metab. 80:320-324.
7. Goodman HG, Grumbach MM, Kaplan SL. 1968 Growth and growth hormone. II. A comparison of isolated growth hormone deficiency and multiple pituitary hormone deficiencies in 35 patients with idioipathic hypopituitary dwarfism. N Engl J Med. 278:57-68.
8. Lippe BM, Van Herle AJ, LaFranchi SH, Uller RP, Lavin N, Kaplan SA. 1975 Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J Clin Endocrinol Metab. 40:612-618.
9. Ranke M, Weber B, Bierich JR. 1979 Long-term response to human growth hormone in 36 childern with idiopathic growth hormone deficiency. Eur J Pediatr. 132:221-238.
10. Rosenbloom AL, Riley WJ, Silverstein JH, Garnica AD, Netzloff ML, Weber FT. 1980 Low dose single weekly injections of growth hormone: response during first year of therapy of hypopituitarism. Pediatrics. 66:272-276.
11. Stahnke N, Koehn H. 1990 Replacement therapy in hypothalamus-pituitary insufficiency: management in the adolescent. Horm Res. 33(Suppl 4):38-44.
12. August GP, Lippe BM, Blethen SL, et. al. 1990 Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. J Pediatr. 116:899-903.
13. Wenzel KW. 1981 Pharmacological interference with in vitro tests of thyroid function. Metabolism. 30:717-732.
14. Lewis GF, Alessi CA, Imperial JG, Refetoff S. 1991 Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab. 73:843-849.
15. Robin NI, Hagfen SR, Collaco F, Refetoff S, Selenkow HA. 1971 Serum tests for measurement of thyroid function. Hormones. 2:266-279.
16. Grunfeld C, Sherman BM, Cavalieri RR. 1988 The acute effects of human growth hormone administration on thyroid function in normal men. J Clin Endocrinol Metab. 67:1111-4.
17. Glantz SA, Slinker BK. 1990 Primer of applied regression and analysis of variance. New York: McGraw-Hill.
18. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. 1979 Physical growth: National Center for Health Statitsics percentiles. Am J Clin Nutr. 32:607-629.
19. Genentech National Cooperative Growth Study. 1994 Summary report. South San Francisco: Genentech.
20. Heimberg M, Olubadewo JO, Wilcox HG. 1985 Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev. 6:590-607.
21. 3) in children with hypopituitarism. Pediatr Res. 15:6-9.
22. Brixen K, Neilsen HK, Bouillon R, Flyvbjerg A, Mosekilde L. 1992 Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. Acta Endocrinol (Copenh). 127:331-336.
23. Root AW, Snyder PJ, Rezvani I, DiGeorge AM, Utiger RD. 1973 Inhibition of thyrotropin-releasing hormone-mediated secretion of thyrotropin by human growth hormone. J Clin Endocrinol Metab. 36:103-107.
24. Sato T, Suzuki Y, Taketani T, et al. 1977 Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. J Clin Endocrinol Metab. 45:324-329.
25. Pirazzoli P, Cacciari E, Mandini M, et al. 1992 Growth and thyroid function in children treated with growth hormone. J Pediatr. 121:210-213.
26. Jorgensen JOL, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS. 1989 Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab. 69:1127-1132.
27. Ho KY, Weissberger AJ, Stuart MC, Day RO, Lazarus L. 1989 The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol (Oxf). 30:335-345.
28. Root AW, Bongiovanni AM, Eberlein WR. 1970 Inhibition of thyroidal radioiodine uptake by human growth hormone. J Pediatr. 76:422-429.
29. Cobb WE, Reichlin S, Jackson IMD. 1981 Growth hormone secretory status is a determinant of the thyrotropin response to thyrotropin-releasing hormone in euthyroid patients with hypothalamic-pituitary disease. J Clin Endocrinol Metab. 52:324-329.
30. Jorgensen JOL, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J. 1994 Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf). 41:609-614.
31. Demura R, Yamaguchi H, Wakabayashi I, Demura H, Shizume K. 1980 The effect of hGH on hypothalamic-pituitary-thyroid function in patients with pituitary dwarfism. Acta Endocrinol (Oxf). 93:13-19.
32. Conners MH. 1977 Alteration of stimulated TSH and prolactin response in children treated with growth hormone. Life Sci. 21:1505-1510.
33. Porter BA, Refetoff S, Rosenfield RL, DeGroot LJ, Fang VS, Stark V. 1973 Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during growth hormone therapy. Pediatrics. 51:668-674.
34. Rubio GR, Mellinger RC, Zafar S, Wolf CB. 1976 Evaluation of thyroid function during growth hormone therapy. Metabolism. 25:15-21.
35. Moller J, Jorgensen J, Moller N, Christiansen JS, Weeke J. 1992 Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism. 41:728-731.
36. Wyatt DT, Mark D, Slyper A. 1995 Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab. 80:3292-3297.
37. Brande JLVd, Van Wyk JJ, French FS, Strickland AL, Radcliffe WB. 1973 Advancement of skeletal age of hypopituitary children treated wtih thyroid hormone plus cortisone. J Pediatr. 82:22-27.
38. Radetti G, Castellan C, Tato L, Platter K, Gentili L, Adami S. 1993 Bone mineral density in children and adolescent females treated with high doses of L-thyroxine. Horm Res. 39:127-131.
39. Franklyn JA, Sheppard MC. 1992 The thyroid and osteoporosis. Trends Endocrinol Metab. 3:113-116.
40. Fazio S, Biondi B, Carella C, et al. 1995 Diastolic dysfunction in patients on thyroid-stimulating homrone suppressive therapy with levothyroxine: beneficial effect of β-blockade. J Clin Endocrinol Metab. 80:2222-2226.